Scarica l'app Stockscreener
29.49
4.61%
1.30
Dopo l'orario di chiusura:
29.90
0.41
+1.39%
Gh Research Plc Borsa (GHRS) Ultime notizie
Zacks Research Upgrades GH Research (NASDAQ:GHRS) to Hold - MarketBeat
RA Capital discloses 7.1% GH Research PLC (GHRS) stake in Schedule 13G/A - Stock Titan
Lynx1 Capital Management (NASDAQ: GHRS) reports 19.3% stake in GH Research - Stock Titan
GH Research PLC (NASDAQ:GHRS) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
GH Research PLC (GHRS) director receives 2,202 fully vested share options - Stock Titan
GH Research PLC (GHRS) director receives 2,202 options at $0.025 strike - Stock Titan
GH Research PLC (GHRS) grants 102,202 share options to director Michael Forer - Stock Titan
GH Research (NASDAQ:GHRS) Sees Strong Trading VolumeShould You Buy? - MarketBeat
FY2026 EPS Estimates for GH Research Boosted by Analyst - MarketBeat
Trading the Move, Not the Narrative: (GHRS) Edition - Stock Traders Daily
H.C. Wainwright reiterates GH Research stock rating on FDA progress - Investing.com
H.C. Wainwright reiterates GH Research stock rating on FDA progress By Investing.com - Investing.com Canada
Is GH Research’s Rising Loss Per Share Reframing the GHRS Cash Burn Narrative? - Sahm
GH Research (NASDAQ:GHRS) Posts Quarterly Earnings Results, Beats Expectations By $0.06 EPS - MarketBeat
GH Research (NASDAQ:GHRS) Upgraded at Wall Street Zen - MarketBeat
GH Research stock hits all-time high at 31.41 USD By Investing.com - Investing.com India
GH Research (NASDAQ:GHRS) Reaches New 12-Month High Following Earnings Beat - marketbeat.com
GH Research stock hits all-time high at 31.41 USD - Investing.com
GH Research (NASDAQ:GHRS) Stock Price Expected to Rise, Cantor Fitzgerald Analyst Says - MarketBeat
GH Research PLC (GHRS) Stock Analysis: A Biotech Powerhouse with 30.55% Upside Potential - DirectorsTalk Interviews
GH Research PLC (GHRS) Stock News Today - TradingKey
GH Research PLC (GHRS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
GH Research PLC Stock 12‑Month Price Target Raised to $41.1, Implies 41% Upside - TradingView
Needham & Company LLC Raises GH Research (NASDAQ:GHRS) Price Target to $39.00 - MarketBeat
GH Research PLC Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
GHRS: GH001 achieves rapid, sustained TRD remission with fewer visits and robust IP protection - TradingView
GH Research (Nasdaq: GHRS) grows cash to $362.7M as R&D spending rises - Stock Titan
GH Research Reports Second Quarter 2026 Financial Results and Provides Business Update - The Manila Times
GH Research Q2 FY26 net loss widens to $15.1 million - Bitget
GH Research says H1 loss widens as R&D spending rises on GH001 clinical, technical development work - Bitget
GH Research (NASDAQ:GHRS) Sees Unusually-High Trading VolumeHere's What Happened - MarketBeat
Is GH Research (GHRS) Trading At A Premium To Fair Value? - Yahoo Finance
Is GH Research (GHRS) Fully Valued Following Its Share Price Surge? - Sahm
(GHRS) Volatility Zones as Tactical Triggers - Stock Traders Daily
GH Research PLC (GHRS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
GH Research (NASDAQ:GHRS) Raised to Strong-Buy at Wells Fargo & Company - MarketBeat
GHRS|GH Research PLC|Price:27.830|Chg%:+0.550 - TradingKey
GH Research PLC (GHRS) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
GHRS Initiated Coverage by Wells Fargo -- Price Target Announced at $44 - GuruFocus
GH Research PLC (GHRS) Institutional Confidence - TradingKey
Troluce Capital Advisors LLC Raises Holdings in GH Research PLC $GHRS - MarketBeat
GH Research PLC (GHRS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
GH Research PLC (GHRS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
GH Research PLC (GHRS) Valuation: PE, PB & Fair Value Analysis - TradingKey
GHRS|GH Research PLC|Price:27.280|Chg%:-0.350 - TradingKey
GH Research PLC (GHRS) Cash Flow - TradingKey
GHRS|GH Research PLC|Price:28.070|Chg%:-0.310 - TradingKey
GH Research PLC Revenue Breakdown – NASDAQ:GHRS - TradingView
GH Research PLC (GHRS) Income Statement - TradingKey
GH Research PLC (GHRS) Balance Sheet - TradingKey
GHRS: GH Research PLC Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
A Depression Drug Just Cleared a Key Hurdle Early, and the Market for New Mental Health Treatments Keeps Widening - marketscreener.com
GH Research PLC (1KA.DU) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Why is GH Research stock trading higher on Thursday? - MSN
GH Research PLC (NASDAQ:GHRS) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Price-Driven Insight from (GHRS) for Rule-Based Strategy - Stock Traders Daily
Samsara Stock And 2 Founder Led Software Picks With Real Revenue Growth - Sahm
Eli Lilly Drops $3.8 Billion on AtaiBeckley, Sending Psychedelic Stocks Soaring - finance.biggo.com
Big Pharma Just Paid Up to $3.8 Billion for Psychedelic Medicine, and the Rest of the Sector Is Being Repriced in Real Time - Finansavisen
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Sahm
AtaiBeckley surges after report Lilly poised to buy psychedelic drug developer - Sahm
0.52%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):